Sector

Sharda Cropchem: A good quarter and a firm outlook

Near-term positive outlook and attractive valuations create room for a stock upside

Chart of the Day: India remains a bright spot for pharma companies

Amid the headwinds in North America, Indian pharma companies continues to see steady growth in India

LatentView’s dismal Q4 a reality check for investors

The stock dropped 10 percent on Wednesday, the second biggest fall since its listing in 2021

Aarti Industries: Is it time to look past inventory headwinds?

FY24 could be another year of consolidation for the industry, unless global growth picks up.

A dismal fourth quarter for UPL

Improvement in industry dynamics and continued efforts to reduce debt level will be key to growth

Chart of the Day: India's hydro pumped storage ambitions make slow progress

The current installed and under construction hydro pumped storage capacities constitute less than 40 percent of the 2030 requirements

PI Industries: Foray into high-margin pharma CDMO business adds to our conviction

CDMO is a robust and fast-growing market. These acquisitions will diversify PI’s business model

Kotak Mahindra Bank – Why we are turning equal-weight after a very strong quarter

Rich valuation, succession issue and recent outperformance are reasons why the stock might not rally at a scorching pace

Chart of the Day: Smaller IT firms cracked the code in Q4

Big IT companies' performance faltered but smaller companies did better and are also more confident about the future. There's a key takeaway for investors too

Why PI Industries is a preferred pick in the agrochemical space

The acquisitions in the pharma API and intermediates business will be earnings and value-accretive.

Soda ash bonanza shows signs of ebbing for Tata Chemicals

The year 2023 is likely to see sizeable additions of soda ash capacities in the global market

Rallis India: Facing a double whammy in the short term

We see an improvement in Rallis’ business in FY24 and view the recent correction as an opportunity for long-term gains

Rallis India, ADAMA results point to more pain for crop care firms

High inventories and falling product prices can undermine profitability, warns Rallis

Chart of the Day | The sun is shining on silver

Rapid addition of solar capacity is driving up demand for silver and its output may lag demand for a third year running

Mankind Pharma IPO: A pricey proposition on branded domestic pharma market

As the company is foraying into newer areas of therapies, particularly chronic, there could be execution hiccups.

Are pharma cos poised for a bull ride? Here's what analysts believe

Alok Dalal of Jefferies believes the $27 billion domestic pharma industry is well-placed to achieve low double-digit growth in the coming years on increased spending on medicines as the population starts to age.

Yes Bank: A no despite likely earnings traction

Business growth of Yes Bank and margin performance will take long to catch up with peers; costs will also remain elevated

Business in the Week Ahead (April 24–28, 2023)

The war in Europe shows no signs of abatement. Though inflation at home is coming off, it’s too early to let your guard drop. Next week, keep an eye out for BoJ's interest rate decision, plus some key macro numbers, including India’s fiscal deficit. An IPO is also on the radar.

US drug shortages rekindle pharma recovery hopes

Drug shortages have increased in the US amid supply chain and manufacturing constraints. Domestic sales are growing too

HCL Tech Q4 FY23 – Navigated the troubled macro well

For HCL Tech, decent deal win, steady hiring, and realistic guidance marked the quarter

Hospital sector likely to firm up on higher occupancy, favourable base in Q4

Most brokerages anticipate that the trend of capacity expansion will persist throughout the sector. Investor attention will remain focused on management commentaries for insights into plans to expand capacity, as well as the potential impact of this on profitability and margins.

Diagnostics: Time to look at this quasi-consumer industry

A bigger landscape of opportunity awaits organised diagnostic chains to increase market share

Chart of the Day: ISG index predicts more pain for as-a-service IT companies

Contract awards in the as-a-service market declined 13 percent in March 2023 quarter but IT services are expected to fare relatively better

For Infosys and TCS, the COVID boom is ending without profit margin repair

The FY24 profit margins of Infosys and TCS are lower than in pre COVID years